Pharmaceutical Grade 1009119-65-6 Daclatasvir Hepatitis C Featured Image

Pharmaceutical Grade 1009119-65-6 Daclatasvir Pro curatio Hepatitis C

Description:

Puritas:≧99.0%

Signa qualitas:Quod erat faciendum

Testimonium:COA, MOA, MSDS, etc.

Capacitas:50Kgs per mense

Fasciae vita:Et duobus annis

Applicatio:inhibitor dapibus nonstructuralis 5A et adhibetur pro curatione hepatitis C

Quadrigis Commodum:Periti export venditionesque quadrigis ad professionem exercere in officinas

Mitte ad nos inscriptio Download as PDF

Product Detail

FAQ

Product Tags

Productumnomen	Daclatasvir2HCl
Synonyma	N, N'-[[1,1'-Biphenyl]-4,4′-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1 -methylethyl)-2-oxo-2,1-ethanediyl]]] acidum biscarbamicum dimethyl niensis hydrochloridi;BMS 790052
CAS Non.	1009119-65-6
Aspectus	Alba ad luteum pulveris
Formulae hypotheticae	C₄₀H₅₀N₈O₆.2(HCl)
M. Pondus	811.81
Consuetudinem	Pharmaceutical Gradus ad Research proposito
stipare	Quod per petitio tua
Repono	Serva in stricta, levis vasis repugnans in loco frigido

Daclatasvir2HCl Cas:1009119-65-6
Items	Standard	Proventus
Characteres	Alba ad luteum pulveris	Pallida pulveris
Aqua contenta	-1.0%	0.25%
Puritas	≧99%	99.7%
una immunditia	-0.1%	0.06%
Reliqua ignitio	-0.1%	Obsequitur
conclusio	Prosequitur domum in- specification.

Company Information

√ Procuratio accumsan plena experientia in technicis et technicis peritissimis sectatoribus;
√ Quality is always our top consideration, Strict QC system;
√ 11 annos periti quadrigis venditio educendi;
√ Independentes R&D lab;
√ Duae officinae GMP terminus signati longi sunt;
√ Divites copiarum otiosorum officinarum copia pro project nativus;
√ High Efficiency working team with consistent path.
imgsaf